Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives Average Recommendation of “Hold” from Analysts

Bioceres Crop Solutions Corp. (NASDAQ:BIOXGet Free Report) has received a consensus rating of “Hold” from the five analysts that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the company. The average 12-month price target among brokers that have covered the stock in the last year is $4.0833.

A number of analysts have weighed in on the stock. Canaccord Genuity Group reduced their price target on shares of Bioceres Crop Solutions from $2.50 to $2.25 and set a “hold” rating for the company in a report on Friday, November 14th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Bioceres Crop Solutions in a research note on Monday. Wall Street Zen raised Bioceres Crop Solutions from a “sell” rating to a “hold” rating in a research report on Saturday, November 22nd. Lake Street Capital reduced their price objective on Bioceres Crop Solutions from $8.00 to $5.00 and set a “buy” rating for the company in a research report on Wednesday, September 10th. Finally, Oppenheimer lowered Bioceres Crop Solutions from an “outperform” rating to a “market perform” rating in a report on Wednesday, October 22nd.

Get Our Latest Research Report on Bioceres Crop Solutions

Institutional Trading of Bioceres Crop Solutions

A number of large investors have recently bought and sold shares of BIOX. Ardsley Advisory Partners LP boosted its holdings in shares of Bioceres Crop Solutions by 4.7% in the 2nd quarter. Ardsley Advisory Partners LP now owns 993,614 shares of the company’s stock worth $4,441,000 after acquiring an additional 45,000 shares in the last quarter. Long Focus Capital Management LLC increased its holdings in Bioceres Crop Solutions by 11.4% in the first quarter. Long Focus Capital Management LLC now owns 829,748 shares of the company’s stock valued at $3,788,000 after purchasing an additional 85,000 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Bioceres Crop Solutions by 9.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 823,916 shares of the company’s stock worth $3,761,000 after buying an additional 71,581 shares during the period. Ballast Asset Management LP increased its stake in shares of Bioceres Crop Solutions by 69.9% in the 3rd quarter. Ballast Asset Management LP now owns 745,030 shares of the company’s stock valued at $1,048,000 after acquiring an additional 306,624 shares during the last quarter. Finally, Susquehanna International Group LLP bought a new position in Bioceres Crop Solutions during the 3rd quarter worth approximately $315,000. 17.68% of the stock is currently owned by institutional investors.

Bioceres Crop Solutions Stock Down 2.6%

Shares of BIOX stock opened at $1.51 on Wednesday. The company has a market capitalization of $95.48 million, a price-to-earnings ratio of -1.80 and a beta of 0.45. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.64 and a current ratio of 0.94. Bioceres Crop Solutions has a twelve month low of $1.20 and a twelve month high of $7.44. The stock’s 50 day simple moving average is $1.68 and its 200 day simple moving average is $2.76.

About Bioceres Crop Solutions

(Get Free Report)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.

See Also

Analyst Recommendations for Bioceres Crop Solutions (NASDAQ:BIOX)

Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.